Research only
All of
ALZ.ORG Research Center Alzheimer's Association International Conference ISTAART Journal Grants TrialMatch Press Donate Contact

AAIC 2013 Highlights


An attendee views a poster presentation. More than 5,000 participants from over 70 countries attended AAIC 2013. A presenter at the Alzheimer's Imaging Consortium discusses her findings. AAIC 2013 celebrated 25 years of discovery, progress and change. A poster presenter shared his research. An attendee pauses as she plans her day. Jacqueline Petterson, female winner of the AAIC 2013 5K Fun/Run Walk, received free registration to AAIC 2014 in Copenhagen. An AAIC banner adorns the Massachusetts State House. An overhead view of Monday's plenary session. At the ISTAART reception, members form new connections with their peers. Attendees listen intently during a Sunday morning symposium session. As the Exhibit Hall opens, attendees rush to explore the booths. More than 100 booths line the floor at the AAIC 2013 Exhibit Hall. Dr. Maria Carrillo, vice president, Medical and Scientific Relations, Alzheimer's Association addresses attendees during the Opening Plenary. Dr. Steven DeKosky presents his research on amyloid PET imaging. The AAIC mobile app allows attendees to plan schedules and view abstract content.


Abstracts from AAIC 2013 are now available through Alzheimer’s and Dementia: The Journal of the Alzheimer’s Association. Under “Articles and Issues,” select “Supplements,” and click on “July” (Vol. 9 Iss.4).

Video highlights


Dr. Heather Snyder of the Alzheimer's Association discusses three Boston-based studies reported on during AAIC 2013, demonstrating the vitality and diversity of the city's Alzheimer's disease research.



Dr. Mary Sano of the Alzheimer's Association Medical and Scientific Advisory Council discusses the results of four research trials investigating new targets for therapies in Alzheimer's disease, and incorporating novel approaches to participant identification and selection.



Dr. David Knopman, a member of the Alzheimer's Association Medical and Scientific Advisory Committee, speaks to new advances in our knowledge about risk factors for Alzheimer's disease, including a study revealing that many types of cancer, and chemotherapy treatments, may be associated with lower risk.



Watch Dr. Maria Carrillo, vice president, Medical and Scientific Relations, Alzheimer’s Association, as she summarizes the significance of additional analyses of IVIG research from bench to bedside.



Dr. Ralph Nixon, Chair, Alzheimer's Association Medical and Scientific Advisory Council, discusses new studies reported at AAIC 2013, including first reports for tau imaging, costs related to misdiagnosis and a review of population-based dementia screening.



Dr. Ronald Petersen, member of the Alzheimer's Association National Board, gives an overview of subjective cognitive decline, a newly emerging concept which may be the earliest clinical sign of Alzheimer's disease.

Stay in the official AAIC hotel block and save

Benefits include convenient access to the conference, on-site housing representatives and numerous opportunities to network and attend ancillary meetings. Register and book your hotel. >>